Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation

NCT03926845 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
200
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Institute of Dermatology, Thailand

Collaborators